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Salt and aldosterone do not
get along with each other:
implication of mineralocorticoid
receptors in the profibrotic action
of aldosterone
To the Editor: Bertocchio et al.1 have published an interesting
review on mineralocorticoid receptor (MR) activation and
blockade in chronic kidney disease.
In animal models aldosterone produces heart, renal, and
vascular ﬁbrosis when animals are fed a high-sodium diet.
This is not reproducible in vivo, as high-sodium diet expands
volume and suppresses renin and aldosterone. Only in
primary aldosteronism sodium infusion does not suppress
plasma aldosterone.
Aldosterone-mediated ﬁbrosis is independent from sodium
balance as demonstrated by the EPHESUS and RALES studies
in which patients also treated with other diuretics could have a
better prognosis when MR antagonists were added.2
We also demonstrated that incubation of human mono-
nuclear leukocytes with aldosterone increases the protein expres-
sion of inﬂammation-related proteins PAI-1 and p22phox
and this effect is reversed by canrenone.3 This letter gives
the chance to report another link between aldosterone and
heart and kidney ﬁbrosis. In 1985 we characterized MRs in
mononuclear leukocytes.4 As inﬂammation is linked to an
invasion of mononuclear leukocytes, rich with MRs, MR
antagonists could block this action, ameliorating and delay-
ing the process of inﬂammation. Another interesting point
to be considered is the direct action of spironolactone on
adrenal glands in reducing the synthesis of aldosterone. We
recently published evidence for reversal of idiopathic primary
aldosteronism by long-term treatment with spironolactone or
potassium canrenoate with normalization of aldosterone after
suspension of the MR blockers.5
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History of nephrology: Ukrainian
aspects
To the Editor:We have read with great interest the ‘Nephrology
crossword: history of nephrology’ published by Magoon et al.1
To our surprise, there are several, to our humble opinion,
important inaccuracies involved in question no. 9. The authors
asked: ‘This surgeon in Russia did the ﬁrst human-to-human
kidney transplant in 1936’. The proposed answer was:
‘VOVONOY’. To the best of our knowledge neither the question
nor the response is true. In fact, the surgeon who performed the
ﬁrst human-to-human cadaveric kidney transplantation was the
Ukrainian Professor Yurii Voronoy (or Jurii Woronoy, depend-
ing on the transcription). It happened on the 3rd of April in
1933, whereas 1936 was the year of its publication.2
Why is it in our opinion important to point out that
Dr Voronoy was neither from Russia nor Russian by origin?
First, Yurii Voronoy was born and worked lifelong on the
territory of present Ukraine. Professor Voronoy’s historical
kidney transplantation was performed in Kherson, one of the
regional centers of Ukraine, which is one of the founding
republics of the USSR.3,4 Second, the ﬁrst human-to-human
cadaveric kidney transplantation is a prime example of how
the subtle communistic propaganda apparatus of the former
Soviet Union effectively established that important intellec-
tual achievements coming from non-Russian republics of the
USSR such as the Ukraine were and apparently still are
automatically considered as being ‘Russian’.
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